Moving Beyond ‘Therapy’ and ‘Enhancement’ in the Ethics of Gene Editing
Since the advent of recombinant DNA technology, expectations (and trepidations) about the potential for altering genes and controlling our biology at the fundamental level have been sky high. These expectations have gone largely unfulfilled. But though the dream (or nightmare) of being able to contr...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Cambridge Univ. Press
2019
|
| In: |
Cambridge quarterly of healthcare ethics
Year: 2019, Volume: 28, Issue: 4, Pages: 695-707 |
| Further subjects: | B
Genetics
B translational research B research ethics B Enhancement B gene editing B Reproductive Medicine |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000naa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1827979984 | ||
| 003 | DE-627 | ||
| 005 | 20221220052652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221220s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S0963180119000641 |2 doi | |
| 035 | |a (DE-627)1827979984 | ||
| 035 | |a (DE-599)KXP1827979984 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Cwik, Bryan |e VerfasserIn |4 aut | |
| 109 | |a Cwik, Bryan | ||
| 245 | 1 | 0 | |a Moving Beyond ‘Therapy’ and ‘Enhancement’ in the Ethics of Gene Editing |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Since the advent of recombinant DNA technology, expectations (and trepidations) about the potential for altering genes and controlling our biology at the fundamental level have been sky high. These expectations have gone largely unfulfilled. But though the dream (or nightmare) of being able to control our biology is still far off, gene editing research has made enormous strides toward potential clinical use. This paper argues that when it comes to determining permissible uses of gene editing in one important medical context—germline intervention in reproductive medicine—issues about enhancement and eugenics are, for the foreseeable future, a red herring. Current translational goals for gene editing research involve a different kind of editing than would be required to achieve manipulation of complex traits such as intelligence, and there are more pressing (and unresolved) questions that need attention if clinical use of gene editing in reproductive medicine ever becomes a possibility. | ||
| 601 | |a Therapie | ||
| 650 | 4 | |a translational research | |
| 650 | 4 | |a Genetics | |
| 650 | 4 | |a research ethics | |
| 650 | 4 | |a Reproductive Medicine | |
| 650 | 4 | |a Enhancement | |
| 650 | 4 | |a gene editing | |
| 773 | 0 | 8 | |i Enthalten in |t Cambridge quarterly of healthcare ethics |d Cambridge : Cambridge Univ. Press, 1992 |g 28(2019), 4, Seite 695-707 |h Online-Ressource |w (DE-627)306655039 |w (DE-600)1499985-7 |w (DE-576)081985010 |x 1469-2147 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2019 |g number:4 |g pages:695-707 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/S0963180119000641 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/moving-beyond-therapy-and-enhancement-in-the-ethics-of-gene-editing/0C3C87FF1344EEC69D5457A4E52B58C8 |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 28 |j 2019 |e 4 |h 695-707 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4235384899 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1827979984 | ||
| LOK | |0 005 20221220052652 | ||
| LOK | |0 008 221220||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-12-06#2BAF3C102E0C9E2AC42333E4CF5DAFD61719BC14 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||
| STA | 0 | 0 | |a Enhancement |
| STB | 0 | 0 | |a Amélioration humaine |
| STC | 0 | 0 | |a Mejoramiento humano |
| STD | 0 | 0 | |a Enhancement <etica medica>,Potenziamento (etica medica),Potenziamento |
| STF | 0 | 0 | |a 神經增強 |
| STG | 0 | 0 | |a Melhoramento humano |
| STH | 0 | 0 | |a Улучшение (медицинская этика) |
| STI | 0 | 0 | |a Ενίσχυση <ιατρική ηθική>,Βελτίωση (ιατρική ηθική),Ενδυνάμωση (ιατρική ηθική) |
| SYE | 0 | 0 | |a Human enhancement |